These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 2438941

  • 21. Cytokeratin expression in human cell lines derived from liver tumors.
    Tokiwa T, Endo A, Namba M.
    Cell Biol Int Rep; 1990 Dec; 14(12):1085-91. PubMed ID: 1707348
    [Abstract] [Full Text] [Related]

  • 22. Diagnostic utility of GLUT1 in the differential diagnosis of liver carcinomas.
    Roh MS, Jeong JS, Kim YH, Kim MC, Hong SH.
    Hepatogastroenterology; 2004 Dec; 51(59):1315-8. PubMed ID: 15362741
    [Abstract] [Full Text] [Related]

  • 23. Expression of cytokeratin 5/6 in epithelial neoplasms: an immunohistochemical study of 509 cases.
    Chu PG, Weiss LM.
    Mod Pathol; 2002 Jan; 15(1):6-10. PubMed ID: 11796835
    [Abstract] [Full Text] [Related]

  • 24. Expression of cytokeratins in normal and diseased livers and in primary liver carcinomas.
    Lai YS, Thung SN, Gerber MA, Chen ML, Schaffner F.
    Arch Pathol Lab Med; 1989 Feb; 113(2):134-8. PubMed ID: 2464975
    [Abstract] [Full Text] [Related]

  • 25. A comparison of A103 and inhibin reactivity in adrenal cortical tumors: distinction from hepatocellular carcinoma and renal tumors.
    Renshaw AA, Granter SR.
    Mod Pathol; 1998 Dec; 11(12):1160-4. PubMed ID: 9872645
    [Abstract] [Full Text] [Related]

  • 26. A novel monoclonal antibody to cytokeratin 18 with reactivity toward lung squamous cell carcinomas and adenocarcinomas of various sites.
    Chin NW, Zhang R, Nostro DC, Lanks KW.
    Am J Pathol; 1992 May; 140(5):1061-9. PubMed ID: 1374589
    [Abstract] [Full Text] [Related]

  • 27. Detection of epithelial- and neural type of intermediate filament proteins in human lung tumors.
    Ramaekers F, Broers J, Rot MK, Oostendorp T, Wagenaar S, Vooijs P.
    Acta Histochem Suppl; 1987 May; 34():45-56. PubMed ID: 3033739
    [Abstract] [Full Text] [Related]

  • 28. Immunocytochemistry of cytokeratins in primary human liver tumors.
    Van Eyken P, Sciot R, Desmet VJ.
    APMIS Suppl; 1991 May; 23():77-85. PubMed ID: 1715730
    [Abstract] [Full Text] [Related]

  • 29. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies.
    Moll R, Löwe A, Laufer J, Franke WW.
    Am J Pathol; 1992 Feb; 140(2):427-47. PubMed ID: 1371204
    [Abstract] [Full Text] [Related]

  • 30. Evidence for a hepatocellular lineage in a combined hepatocellular-cholangiocarcinoma of transitional type.
    Fisher HP, Doppl W, Osborn M, Altmannsberger M.
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1988 Feb; 56(2):71-6. PubMed ID: 2467436
    [Abstract] [Full Text] [Related]

  • 31. Immunohistochemical profiles of Mallory body by a panel of anti-cytokeratin antibodies.
    Pei RJ, Danbara N, Tsujita-Kyutoku M, Yuri T, Tsubura A.
    Med Electron Microsc; 2004 Jun; 37(2):114-8. PubMed ID: 15221653
    [Abstract] [Full Text] [Related]

  • 32. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors.
    Amarapurkar AD, Rege JD, Joshi AS, Vaiphei K, Amarapurkar DN.
    Indian J Pathol Microbiol; 2006 Jul; 49(3):341-4. PubMed ID: 17001880
    [Abstract] [Full Text] [Related]

  • 33. High mobility group A1 is expressed in metastatic adenocarcinoma to the liver and intrahepatic cholangiocarcinoma, but not in hepatocellular carcinoma: its potential use in the diagnosis of liver neoplasms.
    Abe N, Watanabe T, Izumisato Y, Suzuki Y, Masaki T, Mori T, Sugiyama M, Fusco A, Atomi Y.
    J Gastroenterol; 2003 Jul; 38(12):1144-9. PubMed ID: 14714251
    [Abstract] [Full Text] [Related]

  • 34. Independent occurrence of hepatocellular and cholangiocellular cancer nodules in the liver.
    Furuta T, Kanematsu T, Sonoda T, Sugimachi K.
    Eur J Surg Oncol; 1987 Feb; 13(1):69-73. PubMed ID: 3028868
    [Abstract] [Full Text] [Related]

  • 35. Distribution of cytokeratin 19-positive biliary cells in cirrhotic nodules, hepatic borderline nodules (atypical adenomatous hyperplasia), and small hepatocellular carcinomas.
    Terada T, Hoso M, Nakanuma Y.
    Mod Pathol; 1995 May; 8(4):371-9. PubMed ID: 7567933
    [Abstract] [Full Text] [Related]

  • 36. A resected case of a small hepatocellular carcinoma developing within the bile duct.
    Yasui O, Sato T, Andoh H, Kurokawa T, Watanabe D, Sageshima M, Nanjo H.
    J Hepatobiliary Pancreat Surg; 2004 May; 11(3):193-6. PubMed ID: 15235893
    [Abstract] [Full Text] [Related]

  • 37. Diagnostic significance of aquaporin-1 in liver tumors.
    Mazal PR, Susani M, Wrba F, Haitel A.
    Hum Pathol; 2005 Nov; 36(11):1226-31. PubMed ID: 16260277
    [Abstract] [Full Text] [Related]

  • 38. Utilization of hepatocyte-specific antibody in the immunocytochemical evaluation of liver tumors.
    Minervini MI, Demetris AJ, Lee RG, Carr BI, Madariaga J, Nalesnik MA.
    Mod Pathol; 1997 Jul; 10(7):686-92. PubMed ID: 9237179
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.